Neuroone Medical Technologies is trading at $0.82, down 10.80%, with no clear catalyst identified for the October 26 decline.
- The broader market was higher, so market-wide weakness does not explain the move.
- The latest reported company news was an October 22 purchase order for StereoCED research; it was not identified as the cause of the decline.